Iterum Therapeutics plc (ITRMF) Other financing activities (2018 - 2023)

Iterum Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $235000.0 for Q1 2023.

• In Q1 2023, Other financing activities changed N/A year-over-year to $235000.0; the TTM figure through Mar 2023 stood at $1.3 million (changed N/A YoY), while the FY2022 annual figure was $433000.0, down 99.52% from the prior year.
• Other financing activities for Q1 2023 stood at $235000.0, up from -$5000.0 in the prior quarter.
• The five-year high for Other financing activities was $88.6 million in Q1 2021, with the low at -$38.1 million in Q3 2020.
• The 4-year median for Other financing activities is $49000.0 (2019), against an average of $12.3 million.
• Peak annual rise in Other financing activities reached 96681.63% in 2020, while the deepest fall reached 3805300.0% in 2020.
• Iterum Therapeutics' Other financing activities stood at $1000.0 in 2019, then surged by 3647700.0% to $36.5 million in 2020, then sank by 100.01% to -$5000.0 in 2021, then soared by 4800.0% to $235000.0 in 2023.
• Business Quant data shows ITRMF's Other financing activities at $235000.0 in Q1 2023, -$5000.0 in Q3 2021, and $1.0 million in Q2 2021.